ArticleTranslational lung cancer research2023

LRP1B mutation is associated with tumor immune microenvironment and progression-free survival in lung adenocarcinoma treated with immune checkpoint inhibitors.

Ziyi He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.